脑部放疗，上午比下午敏感许多！
' s. U2 x" D8 P# D" X+ I/ @6 }+ ]' D3 F; @0 V- E
% Q1 o8 D" [- a. e1 c% i. H5 m. SCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
; s$ f( F, D9 QGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
8 Q. ~) W& y6 h# f1 hRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.$ k5 o8 K; W2 w" O' j8 p" {
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.$ F+ \8 f' N# }* w G# |+ R$ h
1 W* j: U6 X' {* m% m) FAbstract
+ J3 U& }$ ]6 b7 a7 A/ V& ABACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
3 n3 t+ Y7 C$ x/ G2 A; S* D6 @- [7 H
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
( Z( ~, \, e0 N; s S
/ W" Q; u4 P( D) NRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
5 X. p' A' T( a! i2 |8 c
5 }: E1 c9 b$ \6 I6 _4 \! a: N$ S) vCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
9 @! c. T- [, N) p7 a
0 q- Z# D4 c- N8 T; E. G; p |
1 Q. T H+ r3 U( V* T
显身卡
